S&P 500 Financials Sector SEC Filings — April 07, 2026

07-04-2026

Pioneer Bancorp, Inc. issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 19, 2026 at 9:00 a.m. local time, soliciting votes for the election of three directors, ratification of Bonadio & Co., LLP as independent registered public accounting firm for the year ending December 31, 2026, and a non-binding advisory resolution on Named Executive Officers' compensation. As of the record date March 23, 2026, there were 25,076,801 shares of common stock outstanding, with Pioneer Bancorp, MHC beneficially owning 14,287,723 shares (57.0%) and M3 Funds, LLC owning 1,884,081 shares (7.5%). The Board unanimously recommends voting 'FOR' all proposals, and no directors or executive officers have pledged shares.

• ·Record date for voting eligibility: March 23, 2026
• ·Virtual annual meeting access: https://www.cstproxy.com/pioneerbancorp/2026 (requires 12-digit control number)
• ·Registration deadline for beneficial owners to attend virtually: 5:00 p.m. ET on May 14, 2026
• ·Conference call for listening: +1-800-450-7155 (U.S./Canada toll-free) or +1-857-999-9155 (international), code 4849410#
• ·Articles of Incorporation limit voting rights for holders >10% (except Pioneer Bancorp, MHC)

07-04-2026

Target Hospitality Corp.'s DEF 14A proxy statement seeks stockholder approval for the election of six director nominees at the annual meeting on May 21, 2026. It highlights strong 2025 fiscal year performance, including $320.6 million in total revenue, $53.2 million in Adjusted EBITDA, $66 million in Discretionary Cash Flow, $0 net debt, and ~$740 million in new multi-year awards secured since February 2025, supported by 16,991 beds across 29 communities. The company emphasizes robust corporate governance, stockholder outreach engaging over 80% of shares, and a skilled board with expertise in leadership, operations, finance, and strategy.

• ·Annual meeting scheduled for May 21, 2026
• ·Fiscal year ended December 31, 2025
• ·Board competencies: 6 directors with advanced/expert leadership/business head/administration, business operations, corporate governance, finance/capital allocation/risk management, strategy; 5 with safety, human resources/talent management, board/committee experience; 4 with financial expertise/literacy, government/public policy, M&A/capital markets; 2 with marketing/sales, cybersecurity/IT; 1 with AI data centers/critical infrastructure

07-04-2026

Legato Merger Corp. III is seeking shareholder approval via proxy for an Extension Proposal to amend its memorandum and articles, extending the deadline to complete its initial business combination with Einride beyond May 8, 2026, to avoid liquidation and redemption of public shares. Officers and directors, owning 4,356,475 ordinary shares (16.3% of outstanding shares), intend to vote in favor of the Extension and Adjournment Proposals. Public shareholders retain redemption rights at an estimated $11.00 per share, with potential Insiders' purchases to reduce redemptions, though no such plans are committed.

• ·Extension Proposal requires special resolution (at least two-thirds majority of votes cast).
• ·Adjournment Proposal requires ordinary resolution (simple majority of votes cast).
• ·If Extension not approved, liquidation by May 8, 2026, with public shares redeemed from Trust Account (net of taxes and up to $100,000 dissolution expenses).
• ·Company may seek further extensions if deemed in best interests.
• ·Insiders may purchase Public Shares at <= $11.00/share pre/post-meeting to reduce redemptions, but such shares would not be voted.

07-04-2026

The Travelers Companies, Inc. (TRV) filed its DEF 14A Proxy Statement on April 7, 2026, for the Annual Meeting of Shareholders on May 20, 2026, recommending votes FOR electing eight director nominees (7 independent, average age 63, average tenure 6 years, 50% diverse), ratifying KPMG LLP as independent auditors for 2026, approving executive compensation on a non-binding basis, and amending the 2023 Stock Incentive Plan, while recommending AGAINST two shareholder proposals on climate-related reporting and an independent board chairman. Governance highlights include all non-Executive committees comprised of independent directors, an independent Lead Director, regular executive sessions, and non-employee directors receiving over 50% of compensation in deferred stock units. Executive compensation emphasizes pay-for-performance, with CEO mix of 5% base salary, 32% annual cash bonus, and performance-based equity (mix incomplete in filing excerpt).

• ·Annual Meeting: May 20, 2026, 9:00 a.m. EDT at Hartford Marriott Downtown, 200 Columbus Boulevard, Hartford, CT 06103 (virtual option possible).
• ·Record date: March 23, 2026.
• ·Proxy voting deadlines: 11:59 p.m. EDT on May 19, 2026 (record holders/brokers); May 18, 2026 (401(k) plan).
• ·Shareholder proposals: ITEM 5 – Report on Climate-Related Pricing and Coverage Decisions; ITEM 6 – Independent Board Chairman.

07-04-2026

UniFirst Corp reported revenues of $622,505 thousand for the thirteen weeks ended February 28, 2026, up 3.4% YoY from $602,219 thousand, and $1,243,823 thousand for the twenty-six weeks, up 3.1% YoY from $1,207,127 thousand, driven by growth in Uniform & Facility Service Solutions (+3.2% Q2) and First Aid & Safety Solutions (+12.2% Q2). However, operating income declined 16.7% YoY to $26,014 thousand in Q2 and 17.8% to $71,322 thousand in H1 due to higher cost of revenues (+2.4% Q2) and selling/admin expenses (+11.0% Q2), leading to net income drops of 16.2% to $20,484 thousand in Q2 and 18.8% to $54,847 thousand in H1. Total assets grew slightly to $2,800,398 thousand, but cash and equivalents fell to $151,794 thousand from $203,501 thousand, with H1 operating cash flow down 31.0% to $88,475 thousand.

• ·Acquisition of businesses: $14,627 thousand net cash outflow in H1 FY26 vs $5,374 thousand prior year.
• ·Capital expenditures: $77,284 thousand in H1 FY26 vs $66,086 thousand prior year.
• ·Common stock repurchases: $32,736 thousand in H1 FY26 vs $12,528 thousand prior year.
• ·Property, plant and equipment, net: $848,054 thousand as of Feb 28, 2026 vs $829,622 thousand Aug 30, 2025.

07-04-2026

ADTRAN Holdings, Inc. entered into a second amendment to CEO Thomas R. Stanton's employment agreement on April 6, 2026, eliminating annual PSUs tied to relative total shareholder return (TSR), adjusting long-term financial plan PSUs to be based on Adjusted EBIT subject to TSR adjustment, and modifying anticipated RSU and PSU values. On April 1, 2026, the Compensation Committee approved target long-term PSU awards under the 2024 Employee Stock Incentive Plan for the 2026-2028 performance period to Stanton (170,723 shares), Chief Revenue Officer James D. Wilson (24,908 shares), and CFO Timothy Santo (28,252 shares), with a similar award planned for CTO Christoph Glingener pending subsidiary approvals. The Company will not grant annual market-based PSUs to named executive officers going forward.

• ·Performance period for PSUs: January 1, 2026 through December 31, 2028
• ·Amendment approved by Board upon Compensation Committee recommendation
• ·Exhibits include Second Amendment to CEO Employment Agreement (10.1), Form of 2026 3-Year Performance Shares Agreement (10.2), and Form of 2026 CEO 3-Year Performance Shares Agreement (10.3)

07-04-2026

Healthcare Realty Trust Inc (HR) filed its DEF 14A proxy statement on April 7, 2026, providing XBRL-tagged disclosures on executive compensation for Principal Executive Officer (PEO) Scott and Meredith Moore, covering equity awards, fair value changes, vesting, and dividends from 2021-2025 with no specific performance declines or improvements quantified. The filing details the company's insider trading policy, including quarterly blackouts and pre-clearance requirements, and confirms the Board's February 2026 annual review of director independence under NYSE-aligned standards. No operational or financial performance metrics are reported, maintaining a governance-focused disclosure.

• ·Insider trading policy prohibits trading on material nonpublic information, imposes quarterly blackouts starting one week before quarter-end through one trading day after earnings release, requires pre-clearance for directors/officers, and bans short sales, options, hedging, and pledging.
• ·Director independence review conducted by Nominating and Corporate Governance Committee and Board in February 2026, using categorical standards consistent with NYSE requirements.
• ·Corporate Governance Principles available at www.healthcarerealty.com under Investor Relations.

07-04-2026

XPO, Inc.'s DEF 14A proxy statement for the 2026 Annual Meeting on May 19, 2026 seeks stockholder approval for electing seven director nominees, ratifying KPMG LLP as independent auditor for fiscal 2026, and an advisory vote on executive compensation. Despite a soft freight market, 2025 performance was robust with revenue of $8.16B, operating income of $656M, and adjusted EBITDA of $1.27B; LTL segment delivered adjusted operating income of $775M (up 4% YoY), adjusted EBITDA of $1.13B (up 4% YoY), and improved adjusted operating ratio by 80 basis points to 84%. The company highlights operational gains including yield ex-fuel growth of 6.0% YoY, reduced purchased transportation expenses by over 50% YoY, and a 533% TSR increase since 2022, generating over $19B in stockholder value.

• ·Record date: March 27, 2026; Annual Meeting: May 19, 2026 at 10:00 a.m. ET (virtual at meetnow.global/M6W4LLV)
• ·Average tractor age reduced to 3.7 years at year-end 2025 (vs. 5.9 years at year-end 2022)
• ·Q4 2025 marked fifteenth consecutive quarter of year-over-year on-time performance improvement
• ·Global employee satisfaction score: 7.9 in 2025; survey response rate: 84%
• ·9% share of $52B LTL market based on 2025 industry revenue
• ·Proxy materials and 2025 Form 10-K available at investors.xpo.com

07-04-2026

General Fusion announced participation in key April 2026 energy conferences, including The Economist’s Fusion Fest (April 14, London), Energy Tech Summit (April 15-16, Bilbao), and Canadian Nuclear Association Conference (April 28-30, Ottawa), to promote its Magnetized Target Fusion technology, LM26 machine milestones, and path to public markets via the proposed business combination with Spring Valley Acquisition Corp. III (SVAC) under the January 21, 2026 Business Combination Agreement. While highlighting over 20 years of development and rapid LM26 build in under two years, the filing includes extensive forward-looking statement cautions and risks, such as potential failure to complete the merger, regulatory hurdles, technology commercialization delays, and market volatility.

• ·LM26 aims to achieve plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion for net fusion energy.
• ·General Fusion established in 2002, headquartered in Vancouver, Canada, funded by global energy venture capital.
• ·Spring Valley I completed business combination with NuScale Power (SMR technology); Spring Valley II with Eagle Nuclear Energy Corp. (uranium deposit rights).

07-04-2026

Mattel, Inc. announced that Steve Totzke, President and Chief Commercial Officer, will step down effective May 1, 2026, and transition to Executive Advisor and President, Strategic Transition through December 31, 2026. Sanjay Luthra, Executive Vice President and Managing Director of EMEA and Global Direct-to-Consumer, has been promoted to succeed Totzke as Chief Commercial Officer, reporting to Chairman and CEO Ynon Kreiz. The announcement highlights Totzke's contributions to commercial growth and Luthra's successful leadership in EMEA, ensuring a smooth handover amid a positive outlook on Mattel's brand-centric strategy.

• ·Steve Totzke joined Mattel in 1996, appointed Chief Commercial Officer in 2018, and promoted to President in 2022; served on boards of Toy Association, Mattel Children’s Foundation, and Advisory Board for Women in Toys, Licensing, and Entertainment Association; inducted into Canadian Toy Association Hall of Fame in 2025.
• ·Sanjay Luthra joined Mattel India in 2003, held leadership roles in Eastern Europe and Canada; Chairman of Toy Industries of Europe for past seven years; will be based in El Segundo, California.

07-04-2026

United Airlines Holdings, Inc.'s 2026 Proxy Statement highlights strong 2025 financial performance with pre-tax earnings of $4.3 billion (7.3% margin), net income of $3.4 billion, adjusted diluted EPS of $10.62 (the only U.S. competitor to grow YoY), $8.4 billion operating cash flow, and $2.7 billion free cash flow. Operationally, the company set records carrying 181 million passengers, expanded its network with 29 domestic/Canada and 13 international routes to over 380 destinations, hired over 13,000 employees (total >113,000), and advanced innovations like Starlink on >300 aircraft and Signature interiors on >200 aircraft. While acknowledging industry challenges like the war in Iran and government shutdown, customer satisfaction reached historic highs with a 7-point NPS increase in check-in experience and 85% app usage on travel day.

• ·2026 Annual Meeting of Stockholders scheduled for May 19, 2026 at 9:00 a.m. Central Time (virtual).
• ·Aircraft orderbook includes more than 250 deliveries expected through April 2028.
• ·Operate flights to more than 380 destinations worldwide; only U.S. legacy carrier with service to more than 75.
• ·SAF use expanded to six hubs: LAX, SFO, ORD, IAH, EWR, IAD.
• ·Within two years, expect more than 227,000 screens on more than 1,200 aircraft.

07-04-2026

Equillium, Inc. filed an S-3 registration statement on April 7, 2026, to register for resale up to 18,878,101 shares of common stock by RA Capital Healthcare Fund, L.P., consisting of 1,179,508 shares issued and 17,698,593 shares issuable upon exercise of a pre-funded warrant from a March 2026 private placement that raised approximately $35.0 million at prices of $1.854 per share and $1.8539 per pre-funded warrant share. The company, a clinical-stage biotech developing EQ504 for ulcerative colitis and EQ302 for celiac disease, will receive no proceeds from the resale. RA Capital's beneficial ownership will decrease from 6,606,983 shares (pre-offering) to 1,916,828 shares (2.37%) post-offering, based on 63,226,556 shares outstanding as of March 20, 2026.

• ·Private placement closed on March 13, 2026, pursuant to Securities Purchase Agreement dated March 11, 2026.
• ·Registration Rights Agreement dated March 13, 2026, requires filing registration statement within 30 days of closing.
• ·Pre-funded warrant includes beneficial ownership limitation and is exercisable immediately with no expiration until fully exercised.
• ·Principal executive offices: 2223 Avenida de la Playa, Suite 105, La Jolla, CA 92037.
• ·Common stock listed on Nasdaq Capital Market under symbol 'EQ'.

07-04-2026

Mistras Group, Inc. seeks shareholder approval at the 2026 Annual Meeting to amend its Amended and Restated 2016 Long-Term Incentive Plan by increasing authorized common shares by 1,700,000 to a total of 7,900,000 shares, approved by the Board on February 26, 2026. As of March 20, 2026, 260,957 shares remain available (resulting in 1,960,957 available if approved), with outstanding awards covering 2,160,058 shares and potential dilution of 11.5% based on 31,800,784 shares outstanding. The three-year average annual burn rate is 2.4%, and rejection would limit equity awards, forcing reliance on cash compensation.

• ·Board approval of Amendment: February 26, 2026
• ·Effective date if approved: May 19, 2026 (2026 Annual Meeting date)
• ·Plan expiration date: March 27, 2034
• ·Previous share increases approved: 2020 (to 3,700,000), 2022 (to 4,900,000), 2024 (to 6,200,000)
• ·Plan originally adopted: August 20, 2016
• ·Governance features: no repricing, no discounted options, minimum 1-year vesting (except non-employee directors), clawback policies, stock ownership guidelines
• ·NYSE rules require shareholder approval

07-04-2026

Energy Transition Special Opportunities (formerly Climate Transition Special Opportunities SPAC I) filed an amended S-1/A registration statement on April 7, 2026, for an IPO of Firm Units targeting $150,000,000 in gross proceeds (implied 15 million units at $10 each), with an over-allotment option for up to 2,250,000 additional units. Proceeds from Firm Units and Private Placement will be deposited into a trust account, including a 4.0% deferred underwriting commission of $6,000,000 (up to $900,000 for Option Units). The Sponsor holds 5,750,000 Founder Shares issued for a total of $25,000, with warrants exercisable at $11.50 per share post-Business Combination.

• ·Warrants entitle holder to purchase one Ordinary Share for $11.50, exercisable 30 days after Business Combination, expiring five years after or upon redemption/liquidation
• ·Over-allotment Option exercisable within 45 days of Registration Statement effective date
• ·Company name changed from Climate Transition Special Opportunities SPAC I on September 15, 2025
• ·Founder Shares issued July 30, 2025, with 1-for-1.26605495295 share split on September 4, 2025; 75,000 transferred to director nominees

07-04-2026

On April 1, 2026, Consolidated Water Co. Ltd. promoted Douglas Vizzini from Vice President of Finance to Executive Vice President and Chief Accounting Officer and entered into an employment agreement with him effective that date through December 31, 2027, with potential two-year extensions at the CEO's discretion. The agreement includes an annual base salary of $350,000, a targeted short-term incentive of 25% of base salary, annual RSU grants valued at 20% of base salary, and a monthly automobile allowance starting at $1,750. Termination provisions include severance equal to one year's base salary if not extended, immediate termination for cause, and provisions for incapacity or resignation with six months' notice.

• ·RSUs vest one-third annually over three fiscal years, subject to continued service.
• ·Severance of one year's base salary if CEO elects not to extend term.
• ·Termination for felony conviction or material harm (with 10-day cure period); resignation requires six months' notice.
• ·Incapacity provisions: duties relieved after 60 days, salary reduced to $1,000/year, full medical coverage until recovery; auto-termination after 12 months.

07-04-2026

The U.S. Bankruptcy Court for the Southern District of Texas confirmed the Fourth Amended Chapter 11 Plan of Liquidation for Luminar Technologies, Inc. and its four affiliated debtors on April 3, 2026, following a confirmation hearing on April 1, 2026, with all objections overruled. The debtors filed voluntary Chapter 11 petitions on December 15 and 31, 2025 (Case No. 25-90807), and have operated as debtors in possession since then. The plan proceeds to liquidation, marking a significant adverse development with no ongoing operations highlighted.

• ·Chapter 11 Cases jointly administered under Case No. 25-90807 (CML) in the Southern District of Texas Houston Division
• ·Creditors’ Committee appointed by U.S. Trustee on December 30, 2025
• ·Debtors’ mailing address: 2603 Discovery Drive, Suite 100, Orlando, Florida 32826
• ·Confirmation Hearing held April 1, 2026; Voting and Objection Deadline March 23, 2026

07-04-2026

Opus Genetics announced a strategic financing agreement with Oberland Capital providing up to $155 million in non-dilutive funding via notes, including an initial $35 million tranche and a concurrent $5 million equity investment at $4.48 per share, boosting current cash to approximately $100 million and extending the runway into 2029 to fund pivotal studies for OPGx-LCA5 and OPGx-BEST1. The deal supports accelerating three earlier-stage programs—OPGx-RDH12 (clinic Q4 2026), OPGx-MERTK (end 2026), and OPGx-RHO (2027)—with topline results from OPGx-BEST1 Phase 1/2 Cohort 1 on track for mid-2026. No declines or flat metrics reported; financing terms include 7-year maturity, ~4.1% initial cash interest rate, and partial convertibility.

• ·Initial closing expected April 20, 2026; notes mature 7 years from issuance with 6-year interest-only period and 50% repayment on 6th anniversary.
• ·Notes: floating rate with floor/cap; 50% interest paid-in-kind first 8 quarters; up to 10% principal convertible at $6.72/share.
• ·Additional $35M tranche available on or prior to March 31, 2028 upon LCA5 regulatory milestones.
• ·RDH12 partially funded by RDH12 Alliance; MERTK collaboration with Department of Health - Abu Dhabi.

07-04-2026

Janus Henderson Group plc filed definitive additional materials (DEFA14A) on April 7, 2026, supplementing the proxy statement for the special shareholder meeting on April 16, 2026, to approve the merger with Jupiter Company Limited and Jupiter Merger Sub Limited under the amended Agreement and Plan of Merger dated December 21, 2025. The supplement adds disclosures to the merger background, detailing competing non-binding proposals including Trian/General Catalyst's $46.00 per share cash offer (October 26, 2025) and Victory Capital's $50-$52 per share mixed cash/stock proposals, which were diligenced but not advanced. It also updates unaudited prospective financial information showing steady revenue growth from $2,134 million in 2025E to $2,671 million in 2029E and EBITDA from $786 million to $1,048 million, with no declines noted across projections.

• ·Special meeting scheduled for 9:00 a.m. Denver time on April 16, 2026, at 151 Detroit Street, Denver, CO 80206.
• ·Merger agreement amended by Amendment No. 1 on March 24, 2026.
• ·Supplemental disclosures made to address litigation risks without admitting liability.
• ·Victory Capital proposals conditioned on due diligence, shareholder approvals, and client consents.
• ·Projections assume 5% annual portfolio value increase (2026-2029) and 3% expense inflation.

07-04-2026

Cell Source, Inc. (CLCS) 10-K filing highlights severe financial risks, including a history of operating losses, substantial doubt about continuing as a going concern, defaults on promissory notes, and the need for additional financing. The company, an early-stage biotech with an unproven strategy, faces stock-related risks such as illiquid trading, insider voting concentration, dilution from future issuances, and penny stock status. No positive financial or operational metrics are presented, emphasizing ongoing challenges in clinical development and commercialization.

• ·Licensing milestones: Commence Phase 2 clinical trials by January 1, 2028 (with interim research sponsorship); commence Phase 3 or receive FDA/EMA Marketing Approval by January 1, 2031; First Commercial Sale within 12 months of Marketing Approval; no sales for 12+ months post-commencement triggers potential termination.
• ·License terms: Exclusive worldwide license under Licensed Information and Patents until later of last Patent expiration or 15-year period from FDA New Drug Approval; 'Orphan Drug' status extends coverage.
• ·Patent obligations: Company bears costs for infringement litigation and indemnifies Yeda.

07-04-2026

The Brink’s Company entered into an Amended and Restated Credit Agreement on March 31, 2026, providing a $1.225B refinanced senior secured term loan facility, $1.025B delayed draw term loan commitments, a $1.0B revolving credit facility, and up to $600M in additional upsize revolver commitments primarily to fund its pending acquisition of NCR Atleos Corporation, refinance NCR Atleos indebtedness, and support general corporate purposes. The facilities mature on March 31, 2031, with borrowings bearing interest based on base rate or Term SOFR plus an Applicable Percentage, subject to financial covenants including a maximum Consolidated Net Secured Leverage Ratio of 3.50 to 1.00 (with a 0.50 step-up for acquisitions) and a minimum Consolidated Interest Coverage Ratio of 2.50 to 1.00. No declines or flat performance metrics are reported, as this filing details new financing arrangements replacing prior facilities on substantially equivalent terms.

• ·Facilities mature March 31, 2031, subject to springing maturity tied to specified indebtedness.
• ·Amended and Restated Credit Agreement amends 2017 Credit Agreement and replaces bridge financing from Morgan Stanley.
• ·Press release issued April 6, 2026, announcing the agreement (furnished under Regulation FD).

07-04-2026

S&T Bancorp, Inc. and S&T Bank entered into an amended and restated employment agreement with CEO Christopher McComish, effective January 1, 2026, for a four-year term with automatic annual renewals. The agreement sets a minimum annual base salary of $785,000, target annual bonus of 67% of base salary, and long-term incentive awards with target value of at least 100% of base salary (50% time-vesting, 50% time- and performance-vesting). It includes severance of 2x (or 3x within two years post-change in control) base plus target bonus, COBRA premiums for 24 (or 36) months, and other perks like up to $25,000 annual vehicle allowance and $25,000 legal fee reimbursement, plus one-year post-termination non-compete and non-solicit covenants.

• ·Employment agreement has a four-year initial term with automatic one-year renewals.
• ·Severance benefits conditioned on execution of a release of claims.
• ·Perpetual covenants for nondisclosure of confidential information and non-disparagement.
• ·Non-competition and non-solicitation covenants apply for one year post-termination.

07-04-2026

Ross Stores, Inc. filed its DEF 14A Proxy Statement for the virtual 2026 Annual Meeting of Stockholders on May 20, 2026 at 1:30 p.m. PDT, with a record date of March 24, 2026. Key proposals include electing 9 directors for one-year terms, approving the 2026 Equity Incentive Plan, an advisory vote on executive compensation, and ratifying Deloitte & Touche LLP as independent auditors for the fiscal year ending January 30, 2027. The filing includes standard pay versus performance disclosures for the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers across fiscal years ending January 2022 through January 2026, though specific compensation values are not detailed in the provided content.

• ·Virtual meeting access: www.virtualshareholdermeeting.com/ROST2026
• ·Voting methods available: Internet (www.ProxyVote.com), telephone (1-800-690-6903), or mail
• ·Proxy voting deadline: 11:59 p.m. ET on May 19, 2026
• ·Stockholder list available for inspection 10 days prior to meeting at 5130 Hacienda Drive, Dublin, CA 94568
• ·Pay vs. performance disclosures cover fiscal years 2022-2026 for PEO and Non-PEO NEOs, including metrics like vesting date fair value of equity awards and changes in fair value

07-04-2026

CKX Lands, Inc. filed a proxy statement for its 2026 Annual Meeting of Shareholders on May 7, 2026, seeking approval to elect six directors (Lee W. Boyer, Keith Duplechin, Daniel J. Englander, Max H. Hart, Lane T. LaMure, Eugene T. Minvielle IV), ratify MaloneBailey LLP as independent auditors, approve executive compensation on a non-binding advisory basis, and determine the frequency of future say-on-pay votes (recommending every year). As of April 3, 2026, 2,053,129 shares of common stock were outstanding, held by 256 record shareholders, with significant beneficial ownership by Ottley Properties, LLC (18.0% or 369,610 shares) and William Gray Stream (10.3% or 211,795 shares); no delinquent Section 16(a) reports were identified.

• ·Record date: March 26, 2026; only record holders entitled to vote.
• ·Quorum requires presence of majority of outstanding shares; election of directors by plurality vote.
• ·Broker non-votes have no effect on proposals; ratification of auditors (Item 2) considered routine.

07-04-2026

Crane NXT, Co.'s DEF 14A proxy statement seeks stockholder ratification of Deloitte & Touche LLP as independent auditors and an advisory 'Say-on-Pay' vote on 2025 NEO compensation. Corporate 2025 annual incentive performance achieved a weighted 94% payout, with revenue at 129% of target ($1,568.6M) but adjusted operating profit at 79% ($335.8M) and adjusted free cash flow at 89% ($213.5M). The Security and Authentication Technologies segment reached 100% payout, driven by revenue at 193% of target ($722.0M) but offset by adjusted operating profit at 77% ($147.8M) and free cash flow at 53% ($129.5M).

• ·Corporate incentive metrics weighted 25% revenue / 50% adjusted operating profit / 25% adjusted free cash flow; excludes certain acquisition and restructuring costs.
• ·Security and Authentication Technologies metrics weighted similarly for Mr. Keayes.
• ·NEO target bonus percentages unchanged from 2024 except Mr. Saak increased to 110% of base salary; Ms. DiMaurizio ineligible for 2025 annual incentive.
• ·Exchange rates: 1.3445 USD/GBP for 2025, 1.2521 USD/GBP for 2024.
• ·Audit Committee approved Deloitte budget for 2026 and reappointment on February 17, 2026.

07-04-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on April 7, 2026, disclosing a press release announcing that its RAD division is implementing its first hardware price increase in nearly three years due to market conditions demanding adjustment. The press release is attached as Exhibit 99.1 and furnished under Item 8.01, not deemed filed or material.

• ·Filing explicitly states information is furnished, not filed, and not deemed material.
• ·Date of earliest event reported: April 7, 2026.

07-04-2026

MetLife, Inc. disclosed preliminary unaudited variable investment income for the quarter ended March 31, 2026, estimated at $475 million to $525 million pre-tax, ahead of its quarterly earnings release on May 6, 2026. This compares to full-year 2026 guidance of approximately $1.6 billion pre-tax for variable investment income, which includes private equity, real estate, other funds, and prepayment fees. Actual results may differ materially as financial closing procedures are not yet complete.

• ·Quarterly earnings release and financial supplement scheduled for May 6, 2026.
• ·Variable investment income includes private equity, real estate and other funds, and prepayment fees.
• ·Information not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934.

07-04-2026

Arlo Technologies, Inc. filed an 8-K on April 07, 2026, disclosing Amended and Restated Bylaws as Exhibit 3.1 under Items 5.03 and 9.01. The bylaws outline provisions for corporate offices, stockholder meetings (including advance notice requirements for nominations and proposals), director powers and meetings, committees, officers' roles and duties, indemnification rights, stock-related matters, and general corporate governance. No financial performance data, changes, or metrics are reported.

07-04-2026

PlusAI announced a business update conference call on April 7, 2026, at 4:30 p.m. ET, to discuss commercial milestones including a live joint autonomous truck pilot with Ryder System, Inc. and International Motors on 600-mile routes, advancing SuperDrive™ toward 2027 L4 commercialization, and HyperFoundry™ launch with $25 million contracted value targeting $40–50 million full-year 2026 revenue. The company outlined a path to positive free cash flow in 2027 and readiness for public listing via merger with Churchill Capital Corp IX in Q2 2026. No historical performance data or declines were provided, only forward-looking targets.

• ·Merger with Churchill Capital Corp IX announced in June 2025; intended public listing in Q2 2026.
• ·Targeted 2027 commercial launch of SuperDrive™ for factory-built Level 4 autonomous trucks.
• ·Conference call webcast at https://plus.ai/investors; replay available through April 21, 2026.
• ·Operations headquartered in Silicon Valley with presence in US and Europe.

07-04-2026

RRE Ventures Acquisition Corp., a special purpose acquisition company (SPAC), filed an S-1 registration statement for an initial public offering of 25,000,000 units, each consisting of one Class A ordinary share and one-third of a warrant exercisable at $11.50 per share. Post-offering, and assuming no exercise of the underwriter's over-allotment option and surrender of 1,250,000 founder shares, the company will have 33,333,333 Class A ordinary shares and 15,343,333 warrants outstanding. The sponsor, RRE Sponsor LLC, initially invested $25,000 and holds founder shares, with 2,718,000 Class B shares sold to management team affiliates, third-party investors, and a consultant.

• ·Up to 1,250,000 founder shares subject to forfeiture depending on underwriter’s over-allotment option exercise.
• ·Warrants exercisable 30 days after initial business combination at $11.50 per share, expiring five years post-combination.
• ·Public warrants redeemable at $0.01 if Class A share price >= $18.00 for specified period.

07-04-2026

NXG NextGen Infrastructure Income Fund issued a Notice of Guaranteed Delivery (EX-99.1) for its rights offering under the Prospectus Supplement dated April 6, 2026, and accompanying Prospectus dated July 9, 2025. The form facilitates subscription for common shares via primary subscription and over-subscription privilege, with submissions required by 5:00 p.m. ET on the Expiration Date of April 30, 2026, to Subscription Agent Equiniti Trust Company, LLC. No financial performance metrics or period comparisons are provided in the filing.

• ·Subscription delivery addresses: 55 Challenger Road, Suite #200, Ridgefield Park, New Jersey 07660, Attn: Reorganization Department
• ·Information Agent contact: (800) 207-2872
• ·Guaranteed delivery must be followed by Subscription Certificate by close of business on the first business day after Expiration Date

07-04-2026

PROG Holdings, Inc., through its subsidiary PROG Beach, LLC, completed the acquisition of P-Squared, LLC (Purchasing Power) on January 2, 2026, pursuant to a Unit Purchase Agreement dated December 1, 2025. This Form 8-K/A amends the original filing solely to provide audited financial statements of Purchasing Power for the year ended December 31, 2024 (Exhibit 99.1), unaudited condensed financial statements for the nine months ended September 30, 2025 (Exhibit 99.2), and unaudited pro forma combined financial information for the same periods (Exhibit 99.3). No specific financial metrics or performance changes are detailed in the filing text.

• ·Unit Purchase Agreement dated December 1, 2025
• ·Acquisition completion date: January 2, 2026
• ·Audited financials of Purchasing Power: year ended December 31, 2024 (Exhibit 99.1)
• ·Unaudited financials of Purchasing Power: nine months ended September 30, 2025 (Exhibit 99.2)
• ·Pro forma combined financials: nine months ended September 30, 2025 and year ended December 31, 2024 (Exhibit 99.3)

07-04-2026

Talkspace, Inc. announced a merger agreement dated March 9, 2026, with Universal Health Services, Inc. (UHS) and its subsidiary UHS Merger Subsidiary, Inc., under which Merger Sub will merge with Talkspace, with Talkspace surviving as an indirect wholly owned subsidiary of UHS. The Board unanimously approved the agreement, declared it advisable and fair to shareholders, and recommends voting FOR the merger proposal (requiring majority of outstanding shares), the advisory compensation proposal, and the adjournment proposal at a virtual special meeting scheduled for 2026. No financial terms such as merger consideration are detailed in this preliminary proxy statement.

• ·Merger agreement dated March 9, 2026.
• ·Special meeting to be held virtually on [date], 2026, via www.proxydocs.com/TALK.
• ·Record date: [date], 2026.
• ·Merger proposal requires affirmative vote of majority of outstanding shares entitled to vote; abstentions and broker non-votes count as AGAINST.
• ·Proxy solicitor: Innisfree M&A Incorporated.
• ·Company address: 622 Third Avenue, New York, New York 10017.

07-04-2026

Teamshares Inc. and Live Oak Acquisition Corp. V (NASDAQ: LOKV) announced the filing of their joint registration statement on Form S-4 with the SEC on April 3, 2026, in connection with their proposed business combination, a key step toward Teamshares becoming publicly traded. The combined company is expected to operate as Teamshares Inc. and list on Nasdaq under ticker 'TMS', with closing anticipated in Q2 2026, subject to shareholder approval, SEC effectiveness, and other conditions. Teamshares, a tech-enabled acquiror of SMEs, operates subsidiaries with consolidated revenue of over $400 million across over 40 industries and 30 states.

• ·S-4 registration statement filed April 3, 2026
• ·Business combination previously announced November 14, 2025
• ·Teamshares founded in 2019
• ·Acquires SMEs with $0.5 to $5 million EBITDA
• ·Live Oak V address: 4921 William Arnold Road, Memphis, Tennessee, 38117

07-04-2026

Xponential Fitness, Inc. announced its Board of Directors has initiated a review of strategic alternatives to maximize shareholder value, potentially including a sale, merger, or other transaction, and engaged Jefferies LLC as financial advisor. Separately, the Board appointed Nicole Parent Haughey as an independent director, while Jair Clarke, Chelsea A. Grayson, and Bruce Haase stepped down from the Board. CEO Mike Nuzzo stated the team will continue executing its strategy amid the process.

• ·Operates franchise, master franchise, and international expansion agreements in 49 U.S. states, Puerto Rico, and 28 additional countries.
• ·Nicole Parent Haughey previously served as COO of Island Creek Oysters and Mimeo, and held roles at Vertical Research Partners, United Technologies, and Credit Suisse.
• ·References risks in Annual Report on Form 10-K for year ended December 31, 2025.

07-04-2026

Starton Holdings, Inc., a clinical-stage biotechnology company focused on continuous delivery technologies for cancer treatments targeting hematologic malignancies, filed Amendment No. 3 to its S-1 registration statement for an initial public offering of 6,666,667 shares of common stock priced between $5.00 and $7.00 per share, with plans to list on Nasdaq Capital Market under the symbol 'STA'. The underwriters have a 45-day option to purchase up to 1,000,000 additional shares to cover over-allotments. As an emerging growth company and smaller reporting company, it emphasizes high investment risk and reduced reporting requirements.

• ·Filing date: April 7, 2026 (as filed with SEC on April 6, 2026)
• ·SEC file number: 333-292059
• ·Principal executive offices: 215 College Road, Suite 300, Paramus, NJ 07652
• ·Fiscal year end: March 31
• ·EIN: 33-2448745
• ·Standard Industrial Classification: Pharmaceutical Preparations [2834]
• ·Estimated IPO price per share: $5.00 to $7.00

07-04-2026

APEX Tech Acquisition Inc., a SPAC, reported a net loss of $39,322 for the three months ended February 28, 2026, a 371% worsening from the $8,349 loss in the prior three-month period, and a total net loss of $47,671 for the six months ended February 28, 2026. The company successfully completed its IPO, depositing $111,971,310 into the Trust Account from public units and adding $2,089,710 from private units, resulting in total assets of $112,555,390, up dramatically from $28,000 at August 31, 2025. Cash balance increased to $584,080, while shareholders' equity rose to $584,080 from $7,953 over the same period.

• ·Underwriter’s partial exercise of over-allotment option to purchase 1,197,131 units on February 27, 2026, resulting in 299,283 ordinary shares no longer subject to forfeiture.
• ·Forfeiture of 75,717 founder shares during the period.
• ·Sponsor retroactively increased purchase of ordinary shares from 1,725,000 to 2,875,000 for $25,000.
• ·Net cash used in operating activities: $39,671 for six months ended February 28, 2026.

07-04-2026

Flushing Financial Corporation's stockholders overwhelmingly approved the merger proposal with OceanFirst Financial Corp. at a special meeting on April 2, 2026, with 24,102,136 votes in favor (97.3% of shares represented), 628,640 against, and 40,182 abstentions out of 24,770,958 shares represented (73.1% quorum of 33,883,626 outstanding shares). However, the advisory compensation proposal for named executive officers passed narrowly with 12,435,187 votes for (50.2%) versus 12,222,100 against and 113,671 abstentions. Under the merger terms, each Flushing share will convert to 0.85 shares of OceanFirst common stock.

• ·Joint press release issued April 6, 2026, announcing voting results.
• ·Merger involves two-step process: Merger Sub into Flushing, then Flushing into OceanFirst.
• ·OceanFirst stockholder meeting also held April 2, 2026.
• ·Proposed Warburg Pincus investment in OceanFirst equity securities.

07-04-2026

InTrack Investment Management Inc. filed its 13F-HR report disclosing total equity holdings of $175,479,569 as of March 31, 2026, across 108 positions in stocks and ETFs. Top holdings include iShares Core S&P 500 ETF ($6,978,039), Fidelity Covington Trust Enhanced International ($6,498,851), Apple Inc. ($6,379,565), and iShares 3-7 Year Treasury Bond ETF ($5,985,432). The portfolio is managed by Myron Sopher, Managing Partner and CCO, based in South Burlington, VT.

• ·Report filed on April 07, 2026 for period ending March 31, 2026
• ·All holdings reported as sole voting authority
• ·Business address: 1233 Shelburne Road, Suite D6B, South Burlington, VT 05403
• ·SEC file number: 028-21062

07-04-2026

CPI Aerostructures Inc reported a net loss of $843,361 for the year ended December 31, 2025, compared to net income of $3,299,334 in 2024, driven by a 14.6% YoY revenue decline to $69,262,124 from $81,078,864 and a 38.7% drop in gross profit to $10,556,069. Total assets grew 10.7% to $75,244,501, supported by increases in operating lease assets and deferred tax assets, however cash balance plunged 83.6% to $899,199 and operating cash flow shifted to negative $5,200,025 from positive $3,558,935. Shareholders' equity remained relatively flat, decreasing slightly to $25,807,574 from $25,933,242.

• ·Cost of sales procurement decreased to $36,588,501 from $40,383,090; labor costs fell to $5,924,180 from $7,303,563; factory overhead flat at ~$16.2M.
• ·Line of credit reduced to $8,373,672 net of current portion from $14,640,000.
• ·New long-term debt of $9,690,890 in 2025.
• ·Operating lease right-of-use assets increased to $9,515,207 from $2,856,200 due to lease amendment adding $8,190,636 non-cash.

07-04-2026

On April 6, 2026, lenders under Inotiv, Inc.'s Credit Agreement, dated November 5, 2021, granted a limited waiver of the minimum liquidity covenant specifically for the April 3, 2026 and April 10, 2026 liquidity test dates. The waiver does not amend any provisions of the Credit Agreement. This event highlights potential liquidity pressures but provides temporary relief without altering underlying terms.

• ·Filing submitted on April 7, 2026, pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
• ·Registrant incorporated in Indiana, Commission File Number 0-23357, IRS Employer Identification No. 35-1345024

07-04-2026

Protagenic Therapeutics, Inc. notified Alexander Arrow, MD, its Chief Financial Officer, that his employment will be terminated effective April 30, 2026, with the board notification occurring on March 31, 2026. No replacement has been announced, representing a key leadership transition. The filing was signed by Executive Chairman Garo H. Armen.

• ·Filing signed on April 6, 2026, and dated April 7, 2026

07-04-2026

Velo3D, Inc. appointed James Suva as Chief Financial Officer and principal financial and accounting officer, effective April 6, 2026, as previously disclosed on March 20, 2026. Under the offer letter effective March 5, 2026, Mr. Suva receives an annual base salary of $380,000 and a target bonus for fiscal 2026 equal to 70% of his base salary. The Compensation Committee granted 135,000 RSUs vesting 25% on May 15, 2027, and 1/16th quarterly thereafter subject to continued service.

• ·Offer letter entered April 6, 2026, effective March 5, 2026; at-will employment with customary confidentiality covenants
• ·RSU vesting on Quarterly Vest Dates: February 15, May 15, August 15, November 15
• ·Offer letter filed as Exhibit 10.1

07-04-2026

EVERTEC, Inc. (EVTC) filed a DEFA14A form on April 07, 2026, classified as Definitive Additional Materials under Schedule 14A Proxy Statement. This filing serves as additional proxy solicitation materials pursuant to Section 14(a) of the Securities Exchange Act of 1934. No financial metrics, performance data, or substantive business updates are included in the provided filing header.

• ·Filing Type: DEFA14A
• ·Subcategory: Proxy Statement
• ·No fee required for filing

07-04-2026

Sphere 3D Corp. is seeking shareholder approval at a special virtual meeting for the acquisition of Cathedra via an Arrangement Agreement, involving the issuance of approximately 4,203,089 Sphere Common Shares (42% of outstanding on a fully diluted basis), resulting in former Sphere shareholders owning 58% and former Cathedra shareholders 42% of the combined company post-transaction. Additional proposals include fixing the board size at five directors, electing five new director nominees, amending the incentive plan to increase available shares from 639,252 to 2,139,252 (adding 1,500,000 shares), and authorizing a potential share consolidation on a 1-for-up to 5 basis, which introduces dilution risk but aims to enhance capital structure flexibility. Completion of the Arrangement requires approvals for share issuance, board size, director election, and incentive plan, plus court and regulatory approvals, but is not conditioned on consolidation.

• ·Special meeting held virtually; quorum requires 33 1/3% of shares present.
• ·Share Issuance, Board Size, Director Election, and Incentive Plan require majority of votes cast; Consolidation requires 2/3 of votes cast.
• ·Arrangement not conditioned on Consolidation approval.
• ·References financials in 2025 10-K and subsequent 10-Qs available on SEC and Sphere website.

07-04-2026

Four Corners Property Trust (NYSE: FCPT) entered into a new seven-year $200 million senior unsecured delayed draw term loan facility maturing on April 6, 2033, with $50 million drawn at close for immediate investments and general corporate purposes, and the remaining $150 million available for future acquisitions expected in late Q2 and early Q3 2026. The facility is priced at 1.25% over SOFR, supported by BBB/Baa3 ratings, with 96% of term loans hedged and overall debt 98% fixed-rate through November 2027; pro forma run-rate leverage is approximately 5.4x within the 5.0x-6.0x target range. Executives highlighted the attractive pricing and flexibility for accretive investments at 200+ basis points spreads.

• ·Term Loan Facility credit margin: 1.25% over SOFR.
• ·Maturity date: April 6, 2033.
• ·Current senior unsecured debt ratings: BBB (Fitch) / Baa3 (Moody’s).
• ·Stated net leverage range: 5.0x-6.0x.
• ·Facility led by The Huntington National Bank as Administrative Agent.

07-04-2026

News Corporation disclosed copies of information provided to the Australian Securities Exchange (ASX) regarding its ongoing stock repurchase program, under which the company is authorized to acquire up to $1 billion in aggregate of its outstanding Class A common stock (NWSA) and Class B common stock (NWS). These disclosures (Exhibits 99.1-99.4) detail daily ASX notifications as required under ASX rules and include forward-looking statements about potential repurchases subject to market conditions and other factors.

• ·Date of earliest event reported: April 2, 2026
• ·Filing signed and dated: April 7, 2026

07-04-2026

At the April 2, 2026 special stockholder meeting, OceanFirst Financial Corp. shareholders approved the issuance proposal for common stock to Flushing Financial Corporation merger holders and Warburg Pincus affiliates (42,020,260 for, 2,526,694 against, 176,895 abstentions), representing a strong endorsement of the merger and investment. However, the charter amendment to exempt Warburg from certain ownership restrictions was rejected (18,408,853 for, 26,148,179 against, 166,817 abstentions), potentially complicating the transaction. A quorum was met with 44,723,849 shares present out of 57,402,016 outstanding.

• ·Record date for special meeting: February 20, 2026
• ·Joint proxy statement/prospectus dated February 26, 2026
• ·Joint press release issued April 6, 2026 announcing voting results